About
Support the early Oncology clinical drug research and development process by providing strategic planning and execution, including clinical trial design and all aspects of descriptive, diagnostic, predictive and prescriptive analytics of data related to clinical projects like actual trial data, registries and real-world data bases. Represent biostatistics and coordinate the inputs from programing and data management at a substance/asset level regarding data science related aspects. Collaborat...
Updates & Highlights
hrtoday.in · 5 days ago
Boehringer Ingelheim Elevates Sabine Reinig as Global Head of Talent, HR Governance and Analytics
creativeloafing.com · 13 days ago
Watch PAWty Presented by Boehringer Ingelheim
Oncodaily · 15 days ago
Sebastian Pohl on His 3 Year Completion of EACR-Boehringer Ingelheim Postdoctoral Fellowship
Recent Openings
View all 7 jobs arrow_forward(Senior) Principal Clinical Data Scientist
location_on Biberach an der Riß, BW, DE
All Jobs
(Senior) Principal Clinical Data Scientist
location_on Biberach an der Riß, BW, DE
Senior/Principal Clinical Data Scientist HTA
location_on Biberach an der Riß, BW, DE
SR AD/ AD, Principal Clinical Data Scientist -Early Oncology Drug Development (Remote)
location_on Ridgefield, CT, US
SR AD/ AD, Principal Clinical Data Scientist -Early Oncology Drug Development
location_on Ridgefield, CT, US
Culture & Mission
Benefits & Perks
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Boehringer Ingelheim?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentBoehringer Ingelheim Elevates Sabine Reinig as Global Head of Talent, HR Governance and Analytics
Boehringer Ingelheim Elevates Sabine Reinig as Global Head of Talent, HR Governance and Analytics
hrtoday.in · 5 days ago
Watch PAWty Presented by Boehringer Ingelheim
Watch PAWty Presented by Boehringer Ingelheim
creativeloafing.com · 13 days ago
Sebastian Pohl on His 3 Year Completion of EACR-Boehringer Ingelheim Postdoctoral Fellowship
Sebastian Pohl on His 3 Year Completion of EACR-Boehringer Ingelheim Postdoctoral Fellowship
Oncodaily · 15 days ago
Boehringer Ingelheim Achieves Human Animal Bond Certification
Boehringer Ingelheim Achieves Human Animal Bond Certification
PR Newswire · 23 days ago
Boehringer Ingelheim Achieves Human Animal Bond Certification
Boehringer Ingelheim Achieves Human Animal Bond Certification
Yahoo Finance · 23 days ago
Boehringer Ingelheim Advances Potential First-in-Class Triple Receptor Agonist BI 3034701 to Phase 2 for Obesity
Boehringer Ingelheim Advances Potential First-in-Class Triple Receptor Agonist BI 3034701 to Phase 2 for Obesity
BioPharm International · 23 days ago
Boehringer Ingelheim strengthens obesity pipeline as potential first-in-class triple receptor agonist BI 3034701 enters Phase II development
Boehringer Ingelheim strengthens obesity pipeline as potential first-in-class triple receptor agonist BI 3034701 enters Phase II development
GlobeNewswire · 23 days ago
Boehringer Ingelheim reports first-half 2026 sales growth,
Boehringer Ingelheim reports first-half 2026 sales growth,
GlobeNewswire · 24 days ago
Boehringer Ingelheim Posts Sales Growth as Obesity Drug Filing Awaits
Boehringer Ingelheim Posts Sales Growth as Obesity Drug Filing Awaits
WSJ · 24 days ago
Boehringer Ingelheim, BioMed X Form Eye Health Research Team
Boehringer Ingelheim, BioMed X Form Eye Health Research Team
Contract Pharma · about 1 month ago
Boehringer Ingelheim Is a Veeva AI Early Adopter | Veeva
Boehringer Ingelheim Is a Veeva AI Early Adopter | Veeva
Veeva · about 1 month ago
Abu Dhabi's DoH, Boehringer Ingelheim partner to advance research into genetic drivers of diseases
Abu Dhabi's DoH, Boehringer Ingelheim partner to advance research into genetic drivers of diseases
ZAWYA · about 1 month ago
Immunai Signs Discovery Deal With Boehringer Ingelheim
Immunai Signs Discovery Deal With Boehringer Ingelheim
Let's Data Science · about 1 month ago
Boehringer Ingelheim teams with Immunai to find T-cell targets using AI
Boehringer Ingelheim teams with Immunai to find T-cell targets using AI
The Pharma Letter · about 1 month ago
Boehringer Ingelheim Launches Discovery Collaboration with Immunai to Identify Novel T-Cell Targets Across Oncology and Autoimmune Disease
Boehringer Ingelheim Launches Discovery Collaboration with Immunai to Identify Novel T-Cell Targets Across Oncology and Autoimmune Disease
WebWire · about 1 month ago
Israeli-founded AI biotech Immunai launches drug-discovery collaboration with Boehringer Ingelheim
Israeli-founded AI biotech Immunai launches drug-discovery collaboration with Boehringer Ingelheim
The Jerusalem Post · about 1 month ago
Immunai signs up to $15 million research pact with Boehringer Ingelheim
Immunai signs up to $15 million research pact with Boehringer Ingelheim
CTech · about 1 month ago
Lykke Hinsch Gylvin: Three Phase 3 Oncology Trials at Boehringer Ingelheim
Lykke Hinsch Gylvin: Three Phase 3 Oncology Trials at Boehringer Ingelheim
Oncodaily · about 1 month ago
Combotope Therapeutics, Boehringer Ingelheim Partner on Tumor-Selective Antibodies for Cancer
Combotope Therapeutics, Boehringer Ingelheim Partner on Tumor-Selective Antibodies for Cancer
Contract Pharma · about 1 month ago
Boehringer Ingelheim launches three Phase III trials for obrixtamig and zongertinib
Boehringer Ingelheim launches three Phase III trials for obrixtamig and zongertinib
The Clinical Trial Vanguard · about 2 months ago